SUBSEQUENT EVENTS	6 Months Ended
Jun. 30, 2017
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS Update on Series K Preferred Stock Transactions As of August 14, 2017, an additional 3,750 shares of Series K Preferred Stock had been issued in exchange for $3,750,000 in proceeds. There are 1,800 outstanding shares of Series K Preferred Stock, as of the date of this report, representing a value of $1,800,000. On July 28, 2017, 3,000 shares of Series K Preferred Stock was converted into 750,000,000 shares of the Company's common stock. Following this transaction, and as of the date of this report, the Series K investor owns 17.99% of the Company's outstanding common stock. Update on July 2016 Convertible Notes Redemption As of August 14, 2017, additional cash payments of $496,600 and $403,400 had been made on the outstanding principal and interest of the July 2016 Convertible Notes, respectively. As of the date of this report, the principal of the July 2016 Convertible Notes has either been converted or redeemed in full. Update on Series I Exchange Convertible Notes As of August 14, 2017, the Series I Exchange Convertible Notes had been either converted or redeemed in full. On July 26, 2017, the investor converted $20,000 in principal and on July 31, 2017, the investor converted $98,536 in principal and $10,268 in interest. These conversions resulted in the aggregate issuance of 306,675,548 shares of the Company's common stock. Also on July 31, 2017, the Company paid the remaining accrued interest of $5,255 in cash. Update on Series J-1 Preferred Stock On August 10, 2017, the Company entered into a redemption agreement with the holder of the Series J-1 Preferred Stock. In accordance with this agreement, the holder surrendered $700,000 face value of Series J-1 Preferred Stock and $55,305.55 in accrued dividends in exchange for 500,000,000 shares of the Company's common stock and a warrant to purchase 250,000,000 shares of the Company's common stock. The warrant has a fixed exercise price of $0.003 and a term of one year. The warrant may not be exercised if, after giving effect to the exercise, the holder would beneficially own in excess of 9.99% of the Company's outstanding shares of Common Stock. Update on payments on Promissory Notes As of August 14, 2017, additional interest payments of $50,581 had been made on promissory notes issued between December 2016 and April 2017. As of August 14, 2017, principal payments of $20,150 and interest payments of $41,655, had been made on the Promissory Note dated January 17, 2017. Settlement Agreement with Consultant On July 24, 2017, the Company entered into a settlement agreement with a consultant that had been retained by the Company in July 2016. The Company settled all of its obligations with the consultant and canceled the consulting agreement. Under the settlement, the Company will pay the consultant $20,000 in cash and will issue a warrant to the consultant for 250,000,000 shares of common stock. The warrant has a fixed exercise price of $0.004 and a term of one year. The warrant may not be exercised if, after giving effect to the exercise, the holder would beneficially own in excess of 9.99% of the Company's outstanding shares of Common Stock.

SUBSEQUENT EVENTS

Update on Series K Preferred Stock Transactions

As of August 14, 2017, an additional 3,750 shares of Series K Preferred Stock had been issued in exchange for $3,750,000 in proceeds. There are 1,800 outstanding shares of Series K Preferred Stock, as of the date of this report, representing a value of $1,800,000.

On July 28, 2017, 3,000 shares of Series K Preferred Stock was converted into 750,000,000 shares of the Company's common stock. Following this transaction, and as of the date of this report, the Series K investor owns 17.99% of the Company's outstanding common stock.

Update on July 2016 Convertible Notes Redemption

As of August 14, 2017, additional cash payments of $496,600 and $403,400 had been made on the outstanding principal and interest of the July 2016 Convertible Notes, respectively. As of the date of this report, the principal of the July 2016 Convertible Notes has either been converted or redeemed in full.

Update on Series I Exchange Convertible Notes

As of August 14, 2017, the Series I Exchange Convertible Notes had been either converted or redeemed in full. On July 26, 2017, the investor converted $20,000 in principal and on July 31, 2017, the investor converted $98,536 in principal and $10,268 in interest. These conversions resulted in the aggregate issuance of 306,675,548 shares of the Company's common stock. Also on July 31, 2017, the Company paid the remaining accrued interest of $5,255 in cash.

Update on Series J-1 Preferred Stock

On August 10, 2017, the Company entered into a redemption agreement with the holder of the Series J-1 Preferred Stock. In accordance with this agreement, the holder surrendered $700,000 face value of Series J-1 Preferred Stock and $55,305.55 in accrued dividends in exchange for 500,000,000 shares of the Company's common stock and a warrant to purchase 250,000,000 shares of the Company's common stock. The warrant has a fixed exercise price of $0.003 and a term of one year. The warrant may not be exercised if, after giving effect to the exercise, the holder would beneficially own in excess of 9.99% of the Company's outstanding shares of Common Stock.

Update on payments on Promissory Notes

As of August 14, 2017, additional interest payments of $50,581 had been made on promissory notes issued between December 2016 and April 2017.

As of August 14, 2017, principal payments of $20,150 and interest payments of $41,655, had been made on the Promissory Note dated January 17, 2017.

Settlement Agreement with Consultant

On July 24, 2017, the Company entered into a settlement agreement with a consultant that had been retained by the Company in July 2016. The Company settled all of its obligations with the consultant and canceled the consulting agreement. Under the settlement, the Company will pay the consultant $20,000 in cash and will issue a warrant to the consultant for 250,000,000 shares of common stock. The warrant has a fixed exercise price of $0.004 and a term of one year. The warrant may not be exercised if, after giving effect to the exercise, the holder would beneficially own in excess of 9.99% of the Company's outstanding shares of Common Stock.